Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jan 15, 2025; 17(1): 99272
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99272
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99272
Table 2 Comparison of immune function indicators between the two groups before treatment (mean ± SD)
| Group | CD3+ (%) | CD4+ (%) | CD8+ (%) | CD4+/CD8+ | Treg cell (%) | NK cell (%) |
| Observation (n = 58) | 42.86 ± 4.86 | 26.95 ± 3.10 | 31.04 ± 2.08 | 0.87 ± 0.12 | 5.80 ± 1.04 | 30.24 ± 4.85 |
| Control (n = 58) | 43.10 ± 4.96 | 27.05 ± 3.18 | 30.85 ± 2.12 | 0.88 ± 0.13 | 5.76 ± 1.08 | 29.82 ± 4.90 |
| t | 0.263 | 0.171 | 0.487 | 0.430 | 0.203 | 0.464 |
| P value | 0.793 | 0.864 | 0.627 | 0.668 | 0.839 | 0.644 |
- Citation: Shi XJ, Song Y, Liang XX, Chen T, Hao HY, Han X, Chen YN. Effects of Shenqi Xiangyi granules in advanced gastric cancer chemotherapy. World J Gastrointest Oncol 2025; 17(1): 99272
- URL: https://www.wjgnet.com/1948-5204/full/v17/i1/99272.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i1.99272